Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Kulp

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Science Translational Medicine|May 16, 2014
Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIVDevin Sok, Katie J Doores, Bryan Briney, et al.
Cell Reports. Medicine|July 15, 2022
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivoEbony N Gary, Nicholas J Tursi, Bryce Warner, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogenJoseph G Jardine, Takayuki Ota, Devin Sok, et al.
Science (New York, N.Y.)|December 22, 2018
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centersTalar Tokatlian, Benjamin J Read, Christopher A Jones, et al.
Frontiers in Immunology|March 13, 2023
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression <i>in vivo</i>Nicholas J Tursi, Ziyang Xu, Michaela Helble, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
Science (New York, N.Y.)|September 10, 2016
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic miceDevin Sok, Bryan Briney, Joseph G Jardine, et al.
Nature Communications|March 29, 2017
Global site-specific N-glycosylation analysis of HIV envelope glycoproteinLiwei Cao, Jolene K Diedrich, Daniel W Kulp, et al.
Nature Communications|June 25, 2015
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesLaura K Pritchard, Daniel I R Spencer, Louise Royle, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to VaccinationNicholas J Tursi, Colby J Agostino, Jinwei Huang, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Science Translational Medicine|May 16, 2014
Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIVDevin Sok, Katie J Doores, Bryan Briney, et al.
Cell Reports. Medicine|July 15, 2022
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivoEbony N Gary, Nicholas J Tursi, Bryce Warner, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogenJoseph G Jardine, Takayuki Ota, Devin Sok, et al.
Science (New York, N.Y.)|December 22, 2018
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centersTalar Tokatlian, Benjamin J Read, Christopher A Jones, et al.
Frontiers in Immunology|March 13, 2023
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression <i>in vivo</i>Nicholas J Tursi, Ziyang Xu, Michaela Helble, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
Science (New York, N.Y.)|September 10, 2016
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic miceDevin Sok, Bryan Briney, Joseph G Jardine, et al.
Nature Communications|March 29, 2017
Global site-specific N-glycosylation analysis of HIV envelope glycoproteinLiwei Cao, Jolene K Diedrich, Daniel W Kulp, et al.
Nature Communications|June 25, 2015
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesLaura K Pritchard, Daniel I R Spencer, Louise Royle, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to VaccinationNicholas J Tursi, Colby J Agostino, Jinwei Huang, et al.
Pageof 8